Pharmacokinetics, Mass Balance, and Metabolism of [14C]HSK31679 in Healthy Adult Male Volunteers.

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 5, 2023

Primary Completion Date

December 21, 2023

Study Completion Date

December 30, 2024

Conditions

Healthy

Interventions

DRUG

[14C]HSK31679

A single oral dose of 160 mg/100 μCi \[14C\]HSK31679 after fasting for at least 10 hours.

Trial Locations (1)

The First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital), Jinan

All Listed Sponsors

lead

Xizang Haisco Pharmaceutical Co., Ltd

INDUSTRY

NCT06258746 - Pharmacokinetics, Mass Balance, and Metabolism of [14C]HSK31679 in Healthy Adult Male Volunteers. | Biotech Hunter | Biotech Hunter